Program
Insulin, Regular, Human
Also written as “Technosphere Insulin”, “inhaled human insulin” and “Human Insulin Inhalation Powder”.
Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus · Asthma · Diabetes, Gestational, led by 13 companies.
Drug pageInsulin, Regular, Human: every studyMany companies study it; this page follows only the 79 they lead. All 127 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Mannkindits history only | 261 open or running | phase 4since Apr 16, 2021 | Mar 27, 2006 | Mar 2027phase 2 · NCT07224321 |
| Novo Nordiskits history only | 190 open or running | phase 4since Aug 10, 2006 | Jul 17, 2003 | none ahead |
| Eli Lillyits history only | 100 open or running | phase 4since Jan 22, 2013 | Aug 4, 2005 | none ahead |
| Biodelits history only | 50 open or running | phase 3since Oct 5, 2007 | Oct 5, 2007 | none ahead |
| Pfizer | 40 open or running | phase 3since Feb 2, 2006 | Feb 2, 2006 | none ahead |
| Dance Biopharmits history only | 30 open or running | phase 2since Mar 9, 2016 | Mar 9, 2016 | none ahead |
| Halozyme Therapeuticsits history only | 30 open or running | phase 2since Oct 15, 2008 | Jun 24, 2008 | none ahead |
| Sanofiits history only | 30 open or running | phase 4since Jun 26, 2012 | Sep 2, 2010 | none ahead |
| Transdermal Delivery Solutionsits history only | 21 open or running | phase 3since Dec 1, 2021 | Apr 21, 2021 | Oct 15, 2027phase 3 · NCT05159453 |
| Diabetes and Glandular Disease Clinicits history only | 10 open or running | phase 4since Oct 9, 2019 | Oct 9, 2019 | none ahead |
| ikfe-CROits history only | 10 open or running | phase 4since Dec 5, 2011 | Dec 5, 2011 | none ahead |
| Informed Data Systemsits history only | 10 open or running | phase 4since Oct 10, 2017 | Oct 10, 2017 | none ahead |
| The United Laboratories Internationalits history only | 10 open or running | phase 1since May 5, 2026 | May 5, 2026 | none ahead |
Also a collaborator on its studies: Langford Research Institute, Insulet, DexCom, Profil Institut für Stoffwechselforschung, Alkermes, WCCT Global and Nektar Therapeutics.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Pfizer only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 2, 2006First study: phase 3 study in Diabetes MellitusFirst studyNCT00287066 · 22 enrolled · United States
- Aug 29, 2006Phase 3 study in Diabetes Mellitus, Type 2NCT00370565 · 345 enrolled · United States, Canada
- Jan 17, 20072 phase 3 studies in Diabetes Mellitus, Type 1NCT00424437, NCT00424333
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 Pfizer leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT00424437Diabetes Mellitus, Type 1 · United States, Canada | 3 | Completed | 320 | |
| NCT00424333Diabetes Mellitus, Type 1 · United States, Canada | 3 | Completed | 320 | |
| NCT00370565Diabetes Mellitus, Type 2 · United States, Canada | 3 | Completed | 345 | |
| NCT00287066Diabetes Mellitus · United States | 3 | Terminated | 22 |
How it is read
Names in the registry
- “Technosphere Insulin”, 13 entries
- “inhaled human insulin”, 12 entries
- “Human Insulin Inhalation Powder”, 7 entries
- “human insulin”, 7 entries
- “Technosphere® Insulin Inhalation Powder”, 5 entries
Codes read as this program: INH69, INH139, INH208, HR1799.
Conditions, from the studies’ own filings
- Diabetes Mellitus, Type 2, 33 studies
- Diabetes Mellitus, Type 1, 29 studies
- Diabetes Mellitus, 10 studies
- Asthma, 1 study
- Diabetes, Gestational, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.